[Neurologic manifestations related to HTLV-1 viruses]
J C Vernant1, R Bellance, G Buisson
1Service de Neurologie, Hôpital P. Zobda Quitman, Fort-de-France, Martinique.
Abstract:
The human T-cell leukaemia virus type 1 was the first human retrovirus to be isolated in 1980 by R. Gallo and coworkers. As its name indicates, this virus is responsible for adult T-cell leukaemia. In 1985, the neurological manifestations associated with this disease were isolated from the tropical spastic paraplegia group in Martinique. Since that time, such manifestations have been reported in non-tropical countries in other foci of viral endemia and sporadically outside these regions. These neurological manifestations are totally independent of the haematological manifestations with which they are virtually never associated. Frequent in areas of viral endemia, they may be encountered in other countries open to human migrations, where they are too often overlooked.
Insights
Human T-cell leukaemia virus type 1 (HTLV-1) causes adult T-cell leukaemia and distinct neurological conditions. These neurological issues, independent of leukaemia, are often missed in non-endemic regions.
Area of Science:
- Virology
- Neurology
- Infectious Diseases
Context:
- The human T-cell leukaemia virus type 1 (HTLV-1) was first isolated in 1980.
- Neurological manifestations linked to HTLV-1 were identified in 1985.
- These neurological conditions occur independently of the associated leukaemia.
Purpose:
- To highlight the distinct neurological manifestations of HTLV-1.
- To emphasize the importance of recognizing these neurological symptoms.
- To increase awareness of HTLV-1-associated neurological disorders.
Summary:
- Human T-cell leukaemia virus type 1 (HTLV-1) is linked to adult T-cell leukaemia and separate neurological disorders.
- Neurological manifestations, such as those seen in tropical spastic paraplegia, can occur without the haematological disease.
- These neurological conditions are increasingly reported globally, even outside endemic tropical areas.
Impact:
- Increased recognition of HTLV-1-associated neurological diseases in clinical practice.
- Improved diagnosis and management of patients with unexplained neurological symptoms.
- Enhanced understanding of retroviral neurological pathogenesis.
Related Concept Videos
Herpes
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction


